3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
24
Leukemia, Myeloid, Acute
16
Myeloproliferative Disorders
15
Polycythemia Vera
12
Leukemia
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Myelodysplastic Syndromes
9
Thrombocythemia, Essential
8
Graft vs Host Disease
8
Recurrence
6
Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, T-Cell
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Lymphoma, T-Cell, Cutaneous
3
Leukemia, Prolymphocytic, T-Cell
3
Leukemia, Myelomonocytic, Chronic
3
Hematologic Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Bronchiolitis Obliterans Syndrome
3
Triple Negative Breast Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
ruxolitinib
×
1 year
×
Clear all
No trials found.